Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01374295 · ClinicalTrials.gov registry record · NA

Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge

A NA study, sponsored by Albany Medical College.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT01374295: Completed NA study, sponsored by Albany Medical College.

NCT01374295 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01374295, a NA study, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

In order to compare two different forms of patient education; patients who receive Lortab medication or prescription during their ED visit are randomized to receive either standard patient education (from healthcare provider) or video assisted education. After education, patient completes a survey, estimated to take 5 minutes to complete.

Primary Outcome

comparison of patient completed survey following education via standard format or 3 minute video

Interventions

  • OTHER video
  • OTHER standard education

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2011-03
Est. Completion 2012-01
Phase NA
Albany Medical College

52 total trials

What the finished NCT01374295 record still lists

NCT01374295 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which video is the first listed.

NCT01374295 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01374295 about?

NCT01374295 is a clinical study titled "Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge". In order to compare two different forms of patient education; patients who receive Lortab medication or prescription during their ED visit are randomized to receive either standard patient education (from healthcare provider) or video assisted education. After education, patient completes a survey, ...

What is the current status of trial NCT01374295?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2011-03. Estimated completion is 2012-01.

What interventions are being tested in trial NCT01374295?

The interventions under investigation include: video (OTHER), standard education (OTHER).

Who is sponsoring clinical trial NCT01374295?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01374295's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01374295, the US trial registry maintained by the National Library of Medicine. NCT01374295 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.